Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prachi Umbarkar

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cardiovascular Drugs and Therapy|July 23, 2017
Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et alManisha Gupte, Prachi Umbarkar, Hind Lal
Cells|September 28, 2021
Mechanisms of Fibroblast Activation and Myocardial Fibrosis: Lessons Learned from FB-Specific Conditional Mouse ModelsPrachi Umbarkar, Suma Ejantkar, Sultan Tousif, et al.
International Journal of Cardiology|May 30, 2020
Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinibAnand Prakash Singh, Prachi Umbarkar, Sultan Tousif, et al.
Journal of Clinical Medicine|June 19, 2020
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 MitigationAnand Prakash Singh, Sultan Tousif, Prachi Umbarkar, et al.
Free Radical Biology & Medicine|July 10, 2016
Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in Diabetic cardiomyopathySilpa Arkat, Prachi Umbarkar, Sarojini Singh, et al.
American Journal of Physiology. Cell Physiology|September 30, 2024
Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intoleranceManisha Gupte, Prachi Umbarkar, Jacob Lemon, et al.
Pharmacological Research|May 9, 2021
Repurposing Nintedanib for pathological cardiac remodeling and dysfunctionPrachi Umbarkar, Anand P Singh, Sultan Tousif, et al.
Cardiovascular Research|October 16, 2018
Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regenerationAnand Prakash Singh, Prachi Umbarkar, Yuanjun Guo, et al.
Cells|May 6, 2020
Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established ObesityManisha Gupte, Prachi Umbarkar, Anand Prakash Singh, et al.
Cells|February 15, 2022
Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose IntoleranceManisha Gupte, Sultan Tousif, Jacob J Lemon, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cardiovascular Drugs and Therapy|July 23, 2017
Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et alManisha Gupte, Prachi Umbarkar, Hind Lal
Cells|September 28, 2021
Mechanisms of Fibroblast Activation and Myocardial Fibrosis: Lessons Learned from FB-Specific Conditional Mouse ModelsPrachi Umbarkar, Suma Ejantkar, Sultan Tousif, et al.
International Journal of Cardiology|May 30, 2020
Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinibAnand Prakash Singh, Prachi Umbarkar, Sultan Tousif, et al.
Journal of Clinical Medicine|June 19, 2020
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 MitigationAnand Prakash Singh, Sultan Tousif, Prachi Umbarkar, et al.
Free Radical Biology & Medicine|July 10, 2016
Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in Diabetic cardiomyopathySilpa Arkat, Prachi Umbarkar, Sarojini Singh, et al.
American Journal of Physiology. Cell Physiology|September 30, 2024
Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intoleranceManisha Gupte, Prachi Umbarkar, Jacob Lemon, et al.
Pharmacological Research|May 9, 2021
Repurposing Nintedanib for pathological cardiac remodeling and dysfunctionPrachi Umbarkar, Anand P Singh, Sultan Tousif, et al.
Cardiovascular Research|October 16, 2018
Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regenerationAnand Prakash Singh, Prachi Umbarkar, Yuanjun Guo, et al.
Cells|May 6, 2020
Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established ObesityManisha Gupte, Prachi Umbarkar, Anand Prakash Singh, et al.
Cells|February 15, 2022
Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose IntoleranceManisha Gupte, Sultan Tousif, Jacob J Lemon, et al.
Pageof 3